Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
515.72M | 515.77M | 550.42M | 586.87M | 512.92M | 424.07M | Gross Profit |
190.92M | 189.15M | 190.86M | 210.54M | 184.62M | 139.06M | EBIT |
76.03M | 72.78M | 75.05M | 55.09M | 78.17M | 23.91M | EBITDA |
93.88M | 108.17M | 107.19M | 113.22M | -32.58M | 71.98M | Net Income Common Stockholders |
60.36M | 58.11M | 60.53M | 59.58M | -41.87M | 34.69M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
90.29M | 94.33M | 163.88M | 156.91M | 141.47M | 91.77M | Total Assets |
765.53M | 766.11M | 741.17M | 748.49M | 664.46M | 626.05M | Total Debt |
112.20M | 117.09M | 96.86M | 109.36M | 74.75M | 81.06M | Net Debt |
21.91M | 22.76M | -67.02M | -47.55M | -66.72M | -10.72M | Total Liabilities |
227.29M | 235.26M | 214.34M | 242.26M | 200.88M | 202.37M | Stockholders Equity |
538.24M | 530.85M | 526.82M | 506.22M | 463.58M | 423.68M |
Cash Flow | Free Cash Flow | ||||
77.42M | 80.64M | 74.07M | 106.86M | 70.50M | 61.92M | Operating Cash Flow |
96.50M | 99.29M | 88.81M | 121.20M | 86.14M | 76.78M | Investing Cash Flow |
-140.99M | -140.56M | -18.10M | -111.19M | -15.90M | -23.17M | Financing Cash Flow |
-27.53M | -27.93M | -65.40M | 4.34M | -20.71M | -61.33M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | $2.98B | 38.60 | 5.02% | ― | 11.65% | ― | |
73 Outperform | $1.26B | 21.32 | 11.39% | 0.38% | -2.76% | 16.64% | |
68 Neutral | $1.34B | 25.65 | 4.84% | 1.82% | -7.36% | -20.46% | |
65 Neutral | $1.97B | 81.14 | 4.16% | ― | -14.92% | -91.72% | |
64 Neutral | $1.27B | 73.36 | 1.34% | ― | -8.06% | -75.10% | |
60 Neutral | $11.56B | 10.24 | -7.04% | 2.94% | 7.46% | -10.54% | |
51 Neutral | $626.60M | ― | -89.38% | 0.55% | 11.68% | -26360.70% |
On May 8, 2025, CTS held its Annual Meeting of Shareholders where all director nominees were successfully elected, and Proposals 2 and 3 were approved. The meeting included the election of seven directors and the approval of executive compensation and the appointment of Grant Thornton, LLP as the independent registered public accounting firm for the year ending December 31, 2025.
The most recent analyst rating on (CTS) stock is a Hold with a $46.00 price target. To see the full list of analyst forecasts on CTS stock, see the CTS Stock Forecast page.
CTS Corporation announced its financial results for the first quarter of 2025, reporting flat sales of $126 million compared to the previous year, with a 14% increase in sales to diversified markets but a 12% decline in the transportation sector. The company achieved a net income of $13 million, up from $11 million in the first quarter of 2024, and earnings per diluted share increased to $0.44. Despite economic pressures and tariff uncertainties, CTS remains committed to revenue growth and quality of earnings through diversification and strategic acquisitions.
CTS Corporation has released an investor presentation for the fiscal year ending December 31, 2025, highlighting its strategic focus on growth and diversification across various end markets. The company aims to achieve 10% organic and inorganic growth by leveraging its deep custom engineered capabilities, strong customer relationships, and a robust new product pipeline. CTS is positioned to capitalize on megatrends such as automation, healthcare innovation, and electrification, supported by a strong balance sheet and strategic M&A initiatives. The company also emphasizes its commitment to sustainability and efficiency, with a focus on enhancing its core capabilities and expanding its market presence.
On March 5, 2025, Scott D’Angelo, Vice President, Chief Legal and Administrative Officer and Corporate Secretary of CTS Corporation, announced his resignation effective April 4, 2025. His departure was a personal decision to pursue another opportunity and was not due to any disagreement with the company.